Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2004;89:902-907; doi:10.1136/adc.2003.035709
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Archives of Disease in Childhood 2004;89:902-907
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health

ORIGINAL ARTICLE

Systematic review of the dose-response relation of inhaled fluticasone propionate

M Masoli1, M Weatherall2, S Holt3, R Beasley1

1 Medical Research Institute of New Zealand, Wellington, New Zealand
2 Wellington School of Medicine & Health Sciences, Wellington, New Zealand
3 P3 Research, Wellington, New Zealand

Correspondence to:
Correspondence to:
Professor R Beasley
Medical Research Institute of New Zealand, PO Box 10055, Wellington, New Zealand; richard.beasley{at}mrinz.ac.nz

Aims: To examine the dose-response relation of inhaled fluticasone for both efficacy and adrenal function in children with asthma.

Methods: Systematic review of double blind randomised dose-response studies of fluticasone in children of at least 4 weeks duration. Main outcome measures: FEV1, morning peak expiratory flow, night awakenings, ß agonist use, major exacerbations, 12 or 24 hour urinary cortisol, peak plasma cortisol post-stimulation.

Results: Seven studies of 1733 children with asthma met the inclusion criteria for efficacy. The dose-response curve for each efficacy outcome measure suggested that the response began to plateau between 100 and 200 µg per day with additional efficacy at the 400 µg per day dose shown in one study of severe asthmatics. Five studies of 1096 children with asthma met the inclusion criteria for assessment of adrenal function. The largest placebo controlled study of 437 children reported no difference in 24 hour urinary cortisol between placebo and fluticasone at doses of 100 and 200 µg per day. The non-placebo controlled study of 528 children reported significant suppression of overnight urinary cortisol levels with fluticasone at 400 compared with 200 µg per day.

Conclusions: There is insufficient data to determine the dose-response of fluticasone in children at doses >400 µg per day. The dose-response curve for fluticasone appears to plateau between 100 and 200 µg per day for efficacy. There was additional efficacy at the 400 µg per day dose in children with severe asthma; however there was evidence of adrenal suppression at this dose.

Keywords: asthma; fluticasone; efficacy; adrenal function


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

The use of inhaled corticosteroids during childhood: plus ça change...
G Russell
Arch. Dis. Child. 2004 89: 893-895. [Extract] [Full Text] [PDF]

Atoms
Howard Bauchner
Arch. Dis. Child. 2004 89: 893. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Kelly, H W. (2009). Comparison of Inhaled Corticosteroids: An Update. The Annals of Pharmacotherapy 43: 519-527 [Abstract] [Full Text]  
  • Rachelefsky, G. (2009). Inhaled Corticosteroids and Asthma Control in Children: Assessing Impairment and Risk. Pediatrics 123: 353-366 [Abstract] [Full Text]  
  • Turner, S, Thomas, M, von Ziegenweidt, J, Price, D (2009). Prescribing trends in asthma: a longitudinal observational study. Arch. Dis. Child. 94: 16-22 [Abstract] [Full Text]  
  • Nuijsink, M., Hop, W. C. J., Sterk, P. J., Duiverman, E. J., de Jongste, J. C., on behalf of the Children Asthma Therapy Optimal (, (2007). Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 30: 457-466 [Abstract] [Full Text]  
  • Townshend, J, Hails, S, Mckean, M (2007). Management of asthma in children. BMJ 335: 253-257 [Full Text]  
  • Aldous, M. (2007). Adrenal Suppression with High-Dose Fluticasone. AAP Grand Rounds 17: 13-14 [Full Text]  
  • Masoli, M., Weatherall, M., Holt, S., Shirtcliffe, P., Beasley, R. (2006). Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. Eur Respir J 28: 960-967 [Abstract] [Full Text]  
  • Russell, G (2006). Very high dose inhaled corticosteroids: panacea or poison?. Arch. Dis. Child. 91: 802-804 [Full Text]  
  • Paton, J, Jardine, E, McNeill, E, Beaton, S, Galloway, P, Young, D, Donaldson, M (2006). Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch. Dis. Child. 91: 808-813 [Abstract] [Full Text]  
  • Russell, G (2004). The use of inhaled corticosteroids during childhood: plus ca change.... Arch. Dis. Child. 89: 893-895 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs